( NASDAQ-NMS:RGLS )

News from Regulus Therapeutics Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

04 May, 2017, 16:30 ET Regulus Reports First Quarter 2017 Financial Results and Corporate Restructuring

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


27 Apr, 2017, 16:10 ET Regulus to Provide First Quarter 2017 Financial Results on May 4, 2017

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


28 Mar, 2017, 08:30 ET Regulus to Present at the 16th Annual Needham Healthcare Conference

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


02 Mar, 2017, 16:10 ET Regulus Reports Fourth Quarter 2016 Financial Results and Pipeline Update

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


23 Feb, 2017, 16:10 ET Regulus to Release Fourth Quarter and Full Year 2016 Financial Results on March 2, 2017

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines...


16 Feb, 2017, 08:30 ET Regulus Announces Publication in Nature Communications Identifying miR-17 as a Promising Drug Target for ADPKD

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


08 Feb, 2017, 16:10 ET Regulus to Present at Upcoming Healthcare Conferences

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


27 Jan, 2017, 16:10 ET Regulus Announces Continuation of RG-101 Clinical Hold

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


06 Dec, 2016, 16:10 ET Regulus Announces New Drug Development Candidates

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


22 Nov, 2016, 08:00 ET Regulus to Announce New Drug Development Candidates at R&D Day on December 6, 2016

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


01 Nov, 2016, 16:10 ET Regulus Reports Third Quarter 2016 Financial Results

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


25 Oct, 2016, 16:15 ET Regulus to Release Third Quarter Financial Results on November 1, 2016

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


06 Oct, 2016, 16:15 ET Regulus Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


05 Oct, 2016, 08:00 ET Regulus Appoints Timothy M. Wright, M.D. as Chief Research and Development Officer

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


31 Aug, 2016, 08:00 ET Regulus to Present at the 2016 Wells Fargo Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


09 Aug, 2016, 16:10 ET Regulus to Present at the 2016 Wedbush PacGrow Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


02 Aug, 2016, 16:10 ET Regulus Reports Second Quarter 2016 Financial Results

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


27 Jul, 2016, 16:10 ET Regulus Provides Update on Clinical Hold of RG-101

 Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines...


26 Jul, 2016, 16:15 ET Regulus to Release Second Quarter Financial Results on August 2, 2016

 Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


05 Jul, 2016, 08:00 ET Regulus to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


27 Jun, 2016, 16:10 ET Regulus Reports Clinical Hold of RG-101

 Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative...


20 Jun, 2016, 07:00 ET Regulus Secures $30 Million Growth Capital Credit Facility

 Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


07 Jun, 2016, 07:00 ET Regulus Reports Positive Top-line Data

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


03 Jun, 2016, 08:00 ET Regulus to Present at the Jefferies 2016 Healthcare Conference

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


02 Jun, 2016, 16:15 ET Dr. Hugh Rosen Joins Regulus Board of Directors

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...